Gorka Gereñu

Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

Gorka Gereñu, Eva Martišová, Hilda Ferrero et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2017 · 86 citations

Bdnf Cleavage, Alzheimer's Disease, Medicine +12

Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice

Marta Dobarro, Gorka Gereñu · The International Journal of Neuropsychopharmacology · 2013 · 74 citations

Curcumin/Melatonin Hybrid 5-(4-Hydroxy-phenyl)-3-oxo-pentanoic Acid [2-(5-Methoxy-1<i>H</i>-indol-3-yl)-ethyl]-amide Ameliorates AD-Like Pathology in the APP/PS1 Mouse Model

Gorka Gereñu, Kai Liu, Jeremy E. Chojnacki et al. · ACS Chemical Neuroscience · 2015 · 65 citations · Full text

App/ps1 Mouse Model, Synaptic Transmission, Neurochemical Biomarkers +25

Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease

Manuel Rodriguez‐Perdigon, R.M. Tordera, Francisco J. Gil‐Bea et al. · Hippocampus · 2016 · 47 citations

Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice

Francisco J. Gil‐Bea, Gorka Gereñu, Bárbara Aisa et al. · Neurobiology of Disease · 2012 · 38 citations · Full text

Alzheimer's Disease, Cholinergic Denervation, Degenerative Pathology +9